Literature DB >> 21593627

Low-density lipoprotein receptor-related protein is decreased in optic neuropathy of Alzheimer disease.

Lloyd M Cuzzo1, Fred N Ross-Cisneros, Kenneth M Yee, Michelle Y Wang, Alfredo A Sadun.   

Abstract

BACKGROUND: Alzheimer disease (AD) is associated with optic nerve degeneration, yet the underlying pathophysiology of this disease and the optic nerve disorder remain poorly understood. Low-density lipoprotein receptor-related protein (LRP) is implicated in the pathogenesis of AD by mediating the transport of amyloid-β (Aβ) out of the brain into the systemic circulation. As a key player in the reaction to central nervous system injury, astrocytes associate with LRP in AD. This study investigates the role of LRP and astrocytes in the pathogenesis of AD optic neuropathy.
METHODS: To investigate the role of LRP and astrocytes in the pathogenesis of AD optic neuropathy, we conducted immunohistochemical studies on postmortem optic nerves in AD patients (n = 11) and age-matched controls (n = 10) to examine the presence of LRP. Quantitative analyses using imaging software were used to document the extent of LRP in neural tissues. Axonal integrity was assessed by performing immunohistochemistry on the subjects' optic nerves with an antibody to neurofilament (NF) protein. Double-immunofluorescence labeling was performed to investigate whether LRP colocalized with astrocytes, expressing glial fibrillary acidic protein.
RESULTS: LRP expression was decreased in AD optic nerves compared to that in controls (P < 0.001). LRP immunoreactivity was observed in the microvasculature and perivascularly in close proximity to the astrocytic processes. Colocalization of LRP in the astrocytes of optic nerves was also demonstrated. The presence of optic neuropathy was confirmed in the AD optic nerves by demonstrating greatly reduced immunostaining for NF protein as compared to controls.
CONCLUSIONS: The reduction of LRP in the AD degenerative optic nerves supports the hypothesis that LRP may play a role in the pathophysiology of AD optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593627      PMCID: PMC3106991          DOI: 10.1097/WNO.0b013e31821b602c

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  56 in total

Review 1.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

2.  Sequences from the low density lipoprotein receptor-related protein (LRP) cytoplasmic domain enhance amyloid beta protein production via the beta-secretase pathway without altering amyloid precursor protein/LRP nuclear signaling.

Authors:  Il-Sang Yoon; Claus U Pietrzik; David E Kang; Edward H Koo
Journal:  J Biol Chem       Date:  2005-03-16       Impact factor: 5.157

Review 3.  Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.

Authors:  Yan-Jiang Wang; Hua-Dong Zhou; Xin-Fu Zhou
Journal:  Drug Discov Today       Date:  2006-09-07       Impact factor: 7.851

Review 4.  Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation.

Authors:  M Johnsen; L R Lund; J Rømer; K Almholt; K Danø
Journal:  Curr Opin Cell Biol       Date:  1998-10       Impact factor: 8.382

Review 5.  Functional role of the low-density lipoprotein receptor-related protein in Alzheimer's disease.

Authors:  Elaine Waldron; Sebastian Jaeger; Claus U Pietrzik
Journal:  Neurodegener Dis       Date:  2006       Impact factor: 2.977

6.  A quantitative analysis of optic nerve axons in elderly control subjects and patients with Alzheimer's disease.

Authors:  Anila B Syed; Richard A Armstrong; Christopher U M Smith
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

7.  RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.

Authors:  John E Donahue; Stephanie L Flaherty; Conrad E Johanson; John A Duncan; Gerald D Silverberg; Miles C Miller; Rosemarie Tavares; Wentian Yang; Qian Wu; Edmond Sabo; Virginia Hovanesian; Edward G Stopa
Journal:  Acta Neuropathol       Date:  2006-07-25       Impact factor: 17.088

8.  Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease.

Authors:  Pervin K Iseri; Ozgül Altinaş; Tomris Tokay; Nurşen Yüksel
Journal:  J Neuroophthalmol       Date:  2006-03       Impact factor: 3.042

9.  Subcellular localization of the low density lipoprotein receptor-related protein (alpha 2-macroglobulin receptor) in human brain.

Authors:  I Tooyama; T Kawamata; H Akiyama; H Kimura; S K Moestrup; J Gliemann; A Matsuo; P L McGeer
Journal:  Brain Res       Date:  1995-09-11       Impact factor: 3.252

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  3 in total

1.  Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer's disease compared to glaucoma and control.

Authors:  Sevda Aydin Kurna; Gokcen Akar; Ahmet Altun; Yasemin Agirman; Eren Gozke; Tomris Sengor
Journal:  Int Ophthalmol       Date:  2014-10-05       Impact factor: 2.031

2.  Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.

Authors:  Janey L Wiggs; Brian L Yaspan; Michael A Hauser; Jae H Kang; R Rand Allingham; Lana M Olson; Wael Abdrabou; Bao J Fan; Dan Y Wang; Wendy Brodeur; Donald L Budenz; Joseph Caprioli; Andrew Crenshaw; Kristy Crooks; Elizabeth Delbono; Kimberly F Doheny; David S Friedman; Douglas Gaasterland; Terry Gaasterland; Cathy Laurie; Richard K Lee; Paul R Lichter; Stephanie Loomis; Yutao Liu; Felipe A Medeiros; Cathy McCarty; Daniel Mirel; Sayoko E Moroi; David C Musch; Anthony Realini; Frank W Rozsa; Joel S Schuman; Kathleen Scott; Kuldev Singh; Joshua D Stein; Edward H Trager; Paul Vanveldhuisen; Douglas Vollrath; Gadi Wollstein; Sachiko Yoneyama; Kang Zhang; Robert N Weinreb; Jason Ernst; Manolis Kellis; Tomohiro Masuda; Don Zack; Julia E Richards; Margaret Pericak-Vance; Louis R Pasquale; Jonathan L Haines
Journal:  PLoS Genet       Date:  2012-04-26       Impact factor: 5.917

3.  APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease.

Authors:  Qin Zhou; Dantao Peng; Xinrui Yuan; Zeping Lv; Shenghang Pang; Wenyu Jiang; Chuyu Yang; Xiaohong Shi; Guofang Pang; Yige Yang; Haiqun Xie; Wandong Zhang; Caiyou Hu; Ze Yang
Journal:  Neural Regen Res       Date:  2014-03-15       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.